Metraipolis › archive › dc_99f42c4eb299

Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma — Europe PMC PMID:41209553

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41209553
DOI
10.7150/ijms.121880
License (as archived)
solo-consultazione
Archived
2026-11-09T04:49:00.979Z
SHA-256 of the archived text
a84951e5138f2dbfbda6dda4ebf70c2c4c3c67647bb0d2f87e79f01463a006d8
Stable URL of this page
https://metraipolis.com/documento/dc_99f42c4eb299

How to cite

Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma — Europe PMC PMID:41209553 — Europe PMC (en), https://europepmc.org/article/MED/41209553 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99f42c4eb299 (Metraipolis archive dc_99f42c4eb299, sha256 a84951e5138f2dbfbda6dda4ebf70c2c4c3c67647bb0d2f87e79f01463a006d8)
BibTeX
@misc{dc99f42c4eb299,
  title = {Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma — Europe PMC PMID:41209553},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41209553},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99f42c4eb299; sha256 a84951e5138f2dbfbda6dda4ebf70c2c4c3c67647bb0d2f87e79f01463a006d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41209553. Agents can read the archived copy with the MCP tool read_document.